SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-466777
Filing Date
2013-12-09
Accepted
2013-12-09 16:08:33
Documents
1
Period of Report
2013-12-03
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d640785d8k.htm 8-K 11613
  Complete submission text file 0001193125-13-466777.txt   12748
Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23155 | Film No.: 131265717
SIC: 2836 Biological Products, (No Diagnostic Substances)